News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Daily News Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death L.A. McKeown November 11, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Daily News Stimulants Linked to Early Risk of CV Events in Elderly Michael O'Riordan October 25, 2021